TG Therapeutics Inc
Biotechnology
Healthcare
TGTX
161 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
37.40
52 week high
45.51
high
37.49
52 week low
21.31
previous Close
37.30
P/E ratio
market cap
5.06 B
div yield
0
net incoming
3.88 M
-43.60 %
net profit margin
4.63 %
-4.00 %
operating incoming
12.43 M
41.04 %
net change in cash
114 M
1.00 %
cash on hand
196 M
136.19 %
cost of revenue
9.34 M
11.52 %
top